Ischemic strokes related to atrial fibrillation are highly prevalent, presenting with severe
neurologic syndromes and associated with high risk of recurrence. Although advances have …

Atrial fibrillation (AF) is the commonest sustained cardiac rhythm disorder, which is
associated with a substantial risk of mortality and morbidity arising from stroke and …

Importance Atrial fibrillation (AF) is associated with an increase in mortality and morbidity,
with a substantial increase in stroke and systemic thromboembolism. Strokes related to AF …

Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of
this common arrhythmia. Substantial advances in the epidemiology and associated …

Purpose: To characterize the efficacy and safety of anticoagulants and antiplatelet agents for
prevention of stroke in patients with atrial fibrillation. Data Sources: Randomized trials …

Atrial fibrillation (AF) is an important risk factor for stroke. According to a pooled analysis of
controlled clinical trials with warfarin, anticoagulation therapy reduces stroke risk by 62 …

Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial
fibrillation monitoring. Data from stroke registries show that both unknown and untreated or …

In patients with non-valvular atrial fibrillation, oral anticoagulation with vitamin K antagonists
reduces the risk of stroke by more than 60%. But vitamin K antagonists have limitations …

Background: While atrial fibrillation (AF) increases the risk of cardioembolic stroke, some
ischemic strokes in AF patients are noncardioembolic. Objectives: To assess ischemic stroke …

ContextWarfarin has been shown to be highly efficacious for preventing thromboembolism in
atrial fibrillation in randomized trials, but its effectiveness and safety in clinical practice is …